{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:31:29Z","timestamp":1794051089894,"version":"4.8.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Subacute thyroiditis (SAT) is an inflammatory thyroid disease. The main purpose of the treatment is to relieve pain and control the inflammatory process. The aim of the present study was to evaluate the therapeutic effects of steroid and non-steroidal anti-inflammatory drugs (NSAIDs) in SAT. Initial laboratory data, treatment response, and long-term results of 295 SAT patients treated with ibuprofen or methylprednisolone were evaluated. After the exclusion of 78 patients, evaluation was made of 126 patients treated with 1800 mg ibuprofen and 91 patients treated with 48\u2009mg methylprednisolone. In 59.5% of 126 patients treated with ibuprofen, there was no adequate clinical response at the first control visit. In 54% of patients, the treatment was changed to steroids in mean 9.5 days. Symptomatic remission was achieved within two weeks in all patients treated with methylprednisolone. The total recurrence rate was 19.8%, and recurrences were observed more frequently in patients receiving only steroid therapy than in patients treated with NSAID only (23% vs. 10.5% p:0.04). Persistent hypothyroidism developed in 22.8% of patients treated only with ibuprofen and in 6.6% of patients treated with methylprednisolone only. Treatment with only ibuprofen (p:0.039) and positive thyroid peroxidase antibody (anti-TPO) (p:0.029) were determined as the main risk factors for permanent hypothyroidism. NSAID treatment is not as effective as steroid treatment in early clinical remission. Steroid treatment was detected as a protective factor against permanent hypothyroidism. Therefore, steroid therapy may be considered especially in anti-TPO positive SAT patients and patients with high-level acute phase reactants.<\/jats:p>","DOI":"10.1038\/s41598-019-53475-w","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T11:03:48Z","timestamp":1573815828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["An Evaluation of the Results of the Steroid and Non-steroidal Anti-inflammatory Drug Treatments in Subacute Thyroiditis in relation to Persistent Hypothyroidism and Recurrence"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5581-4886","authenticated-orcid":false,"given":"Muhammed Erkam","family":"Sencar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7445-2275","authenticated-orcid":false,"given":"Murat","family":"Calapkulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davut","family":"Sakiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema","family":"Hepsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Kus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Akhanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilknur Ozturk","family":"Unsal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Kizilgul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekir","family":"Ucan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ozbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erman","family":"Cakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"key":"53475_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0300-595X(79)80011-0","volume":"8","author":"R Volp\u00e9","year":"1979","unstructured":"Volp\u00e9, R. Subacute (de Quervain\u2019s) thyroiditis. Clin. Endocrinol. Metab. 8, 81\u201395 (1979).","journal-title":"Clin. Endocrinol. Metab."},{"key":"53475_CR2","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1056\/NEJMra021194","volume":"348","author":"EN Pearce","year":"2003","unstructured":"Pearce, E. N., Farwell, A. P. & Braverman, L. E. Thyroiditis. N. Engl. J. Med. 348, 2646\u201355 (2003).","journal-title":"N. Engl. J. Med."},{"key":"53475_CR3","unstructured":"Hennessey, J. V. Subacute Thyroiditis. Endotext (MDText.com, Inc., 2000)."},{"key":"53475_CR4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross, D. S. et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid 26, 1343\u20131421 (2016).","journal-title":"Thyroid"},{"key":"53475_CR5","doi-asserted-by":"crossref","unstructured":"Groot, L. J. D. E. Painful Hashimoto\u2019s Thyroiditis as an Indication for Thyroidectomy: Clinical Characteristics and Outcome in Seven Patients. 88, 2667\u20132672 (2003).","DOI":"10.1210\/jc.2002-021498"},{"key":"53475_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1089\/thy.2012.0459","volume":"23","author":"S Kubota","year":"2012","unstructured":"Kubota, S. et al. Initial Treatment with 15 mg of Prednisolone Daily Is Sufficient for Most Patients with Subacute Thyroiditis in Japan. Thyroid 23, 269\u2013272 (2012).","journal-title":"Thyroid"},{"key":"53475_CR7","first-page":"489","volume":"39","author":"M Stasiak","year":"2019","unstructured":"Stasiak, M., Michalak, R., Stasiak, B. & Lewinski, A. Clinical characteristics of subacute thyroiditis is different than it used to be - current state based on 15 years own material. Neuro Endocrinol. Lett. 39, 489\u2013495 (2019).","journal-title":"Neuro Endocrinol. Lett."},{"key":"53475_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.7888\/juoeh.37.103","volume":"37","author":"T Arao","year":"2015","unstructured":"Arao, T. et al. Prednisolone dosing regimen for treatment of subacute thyroiditis. J. UOEH 37, 103\u2013110 (2015).","journal-title":"J. UOEH"},{"key":"53475_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","volume":"30","author":"R Melzack","year":"1987","unstructured":"Melzack, R. The short-form McGill Pain Questionnaire. Pain 30, 191\u20137 (1987).","journal-title":"Pain"},{"key":"53475_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0885-3924(01)00409-2","volume":"23","author":"P Poulain","year":"2002","unstructured":"Poulain, P. et al. Pain Measurement Tools and Methods in Clinical Research in Palliative Care. J. Pain Symptom Manage. 23, 239\u2013255 (2002).","journal-title":"J. Pain Symptom Manage."},{"key":"53475_CR11","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1210\/jc.2002-021799","volume":"88","author":"V Fatourechi","year":"2003","unstructured":"Fatourechi, V., Aniszewski, J. P., Fatourechi, G. Z. E., Atkinson, E. J. & Jacobsen, S. J. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J. Clin. Endocrinol. Metab. 88, 2100\u20132105 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"53475_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12020-016-1122-3","volume":"55","author":"J Sato","year":"2017","unstructured":"Sato, J. et al. Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis. Endocrine 55, 209\u2013214 (2017).","journal-title":"Endocrine"},{"key":"53475_CR13","doi-asserted-by":"crossref","unstructured":"Benbassat, C. A., Olchovsky, D., Tsvetov, G. & Shimon, I. Subacute thyroiditis: Clinical characteristics and treatment outcome in fifty-six consecutive patients diagnosed between 1999 and 2005. 631\u2013635 (2007).","DOI":"10.1007\/BF03347442"},{"key":"53475_CR14","doi-asserted-by":"publisher","first-page":"j1415","DOI":"10.1136\/bmj.j1415","volume":"357","author":"AK Waljee","year":"2017","unstructured":"Waljee, A. K. et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ 357, j1415 (2017).","journal-title":"BMJ"},{"key":"53475_CR15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2169\/internalmedicine.40.292","volume":"40","author":"T Mizukoshi","year":"2001","unstructured":"Mizukoshi, T., Noguchi, S., Murakami, T., Futata, T. & Yamashita, H. Evaluation of recurrence in 36 subacute thyroiditis patients managed with prednisolone. Intern. Med. 40, 292\u2013295 (2001).","journal-title":"Intern. Med."},{"key":"53475_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1089\/thy.1997.7.45","volume":"7","author":"FN Bennedbaek","year":"1997","unstructured":"Bennedbaek, F. N. & Hegedus, L. The Value of Ultrasonography in the Diagnosis and Follow-up of Subacute Thyroiditis. Thyroid 7, 45\u201350 (1997).","journal-title":"Thyroid"},{"key":"53475_CR17","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3390\/ijms20051089","volume":"20","author":"M Stasiak","year":"2019","unstructured":"Stasiak, M., Tymoniuk, B., Stasiak, B. & Lewi\u0144ski, A. The Risk of Recurrence of Subacute Thyroiditis Is HLA-Dependent. Int. J. Mol. Sci. 20, 1089 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"53475_CR18","first-page":"1","volume":"2014","author":"BJ Thomas","year":"2014","unstructured":"Thomas, B. J., Porritt, R. A., Hertzog, P. J., Bardin, P. G. & Tate, M. D. Glucocorticosteroids enhance replication of respiratory viruses: Effect of adjuvant interferon. Sci. Rep. 2014, 1\u201311 (2014).","journal-title":"Sci. Rep."},{"key":"53475_CR19","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.106.662114","volume":"115","author":"M Imazio","year":"2007","unstructured":"Imazio, M. et al. Pericardial Disease Indicators of Poor Prognosis of Acute Pericarditis. Circulation 115, 2739\u201344 (2007).","journal-title":"Circulation"},{"key":"53475_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1161\/CIRCULATIONAHA.107.761064","volume":"118","author":"M Imazio","year":"2008","unstructured":"Imazio, M. et al. Corticosteroids for Recurrent Pericarditis: High Versus Low Doses: A Nonrandomized Observation. Circulation 118, 667\u2013671 (2008).","journal-title":"Circulation"},{"key":"53475_CR21","first-page":"221","volume":"19","author":"P Hnilica","year":"1985","unstructured":"Hnilica, P. & Nyulassy, S. Plasma cells in aspirates of goitre and overt permanent hypothyroidism following subacute thyroiditis. Preliminary report. Endocrinol. Exp. 19, 221\u2013226 (1985).","journal-title":"Endocrinol. Exp."},{"key":"53475_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1530\/acta.0.1010348","volume":"101","author":"MJ Tikkanen","year":"1982","unstructured":"Tikkanen, M. J. & Lamberg, B. A. Hypothyroidism following subacute thyroiditis. Acta Endocrinol. (Copenh). 101, 348\u2013353 (1982).","journal-title":"Acta Endocrinol. (Copenh)."},{"key":"53475_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1055\/s-0029-1210522","volume":"87","author":"L Gozariu","year":"2009","unstructured":"Gozariu, L. et al. Late Hypothyroidism Following Subacute Thyroiditis. Exp. Clin. Endocrinol. Diabetes 87, 48\u201352 (2009).","journal-title":"Exp. Clin. Endocrinol. Diabetes"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53475-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53475-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53475-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:06:24Z","timestamp":1671293184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53475-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["53475"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-53475-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]},"assertion":[{"value":"6 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16899"}}